The IGNITE American Innovation Act aims to help small- and mid-sized businesses affected by the COVID-19 pandemic.
In general, the Asian markets have controlled the COVID-19 virus successfully outside of China, but its effect has still led to new developments and trends.
Companies developing technologies that integrate AI need to consider regulatory concerns, community demographics, fitting into existing workflows, technical proficiency of both the hospital personnel and consumers.
Operating with an antiquated QMS raises your risk. Here’s what to consider when modernizing your system.
Investments in new processes and systems must satisfy the needs of the authorities and ensure patient safety and public confidence. Getting it right is likely to be expensive. but regulatory compliance shouldn’t be viewed purely as a cost center.
While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
While connected capabilities and wireless technology certainly lead to greater patient care, they also expose devices to greater cybersecurity risks.
Having the ability to assess vital signs in real time could be the future of monitoring the health of travelers to help prevent outbreaks.
This year’s virtual event features experts from medical device companies, hospitals and government organizations.
As COVID-19 sweeps the globe, it’s becoming increasingly difficult for medical device leaders to navigate the arising challenges and prepare for the future.